Answers are grounded in this paper and cite their sources.
BACKGROUND: Effective infection prevention and control (IPC) programs are essential for preventing healthcare-associated infections and combating antimicrobial resistance (AR), particularly in low- and middle-income countries (LMICs). The Global Fund's COVID-19 Response Mechanism (C19RM) created an opportunity for countries to receive funding to strengthen IPC and AR programs. In 2022, the United States Centers for Disease Control and Prevention, in partnership with the CDC Foundation, provided technical assistance (TA) to seven countries that received C19RM IPC and AR funds. This manuscript describes an evaluation of the TA program. METHODS: TA was delivered by in-country consultants and US-based experts via virtual engagement and in-person visits. A mixed-methods evaluation was conducted, analyzing monitoring data, surveys, and key informant interviews. Guided by the CDC Framework for Program Evaluation and an adapted Kirkpatrick Model, the evaluation assessed TA delivery and recipient satisfaction and perceptions of TA. RESULTS: All 12 survey respondents reported satisfaction, noting that TA increased C19RM funding awareness and supported proposal development, with approximately $14 million in C19RM IPC and AR funds awarded in their countries. Recipients perceived improved capacity to plan, implement, coordinate, and monitor IPC and AR activities. CONCLUSIONS: These findings highlight the value of tailored TA for IPC and AR programs.
No takes yet. Share an insight, caveat, or question.
Nsoh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: